Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Levi

Showing results (151-160 of 198) with videos related to

Pageof 20
Sort By:
American Journal of Physiology. Renal Physiology|October 12, 2023
Farnesoid X receptor prevents neutrophil extracellular traps via reduced sphingosine-1-phosphate in chronic kidney diseaseBryce A Jones, Komuraiah Myakala, Mahilan Guha, et al.
Ebiomedicine|August 5, 2017
The Mechanism of Diabetic Retinopathy Pathogenesis Unifying Key Lipid Regulators, Sirtuin 1 and Liver X ReceptorSandra S Hammer, Eleni Beli, Nermin Kady, et al.
Cell Death and Differentiation|May 15, 2025
Cockayne syndrome mice reflect human kidney disease and are defective in de novo NAD biosynthesisKomal Pekhale, Vinod Tiwari, Mansoor Hussain, et al.
Journal of the American Heart Association|June 26, 2014
Endoplasmic reticulum stress effector CCAAT/enhancer-binding protein homologous protein (CHOP) regulates chronic kidney disease-induced vascular calcificationShinobu Miyazaki-Anzai, Masashi Masuda, Kimberly M Demos-Davies, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 25, 2012
Synthetic farnesoid X receptor agonists induce high-density lipoprotein-mediated transhepatic cholesterol efflux in mice and monkeys and prevent atherosclerosis in cholesteryl ester transfer protein transgenic low-density lipoprotein receptor (-/-) miceEva Hambruch, Shinobu Miyazaki-Anzai, Ulrike Hahn, et al.
The American Journal of Pathology|April 19, 2020
An in Situ Atlas of Mitochondrial DNA in Mammalian Tissues Reveals High Content in Stem and Proliferative CompartmentsJiayu Chen, Qizhi Zheng, Lauren B Peiffer, et al.
Biomedical Optics Express|May 16, 2019
Fully automated analysis of OCT imaging of human kidneys for prediction of post-transplant functionBrandon Konkel, Christopher Lavin, Tong Tong Wu, et al.
Proteomics. Clinical Applications|June 26, 2024
Quantifying Protein Acetylation in Diabetic Nephropathy from Formalin-Fixed Paraffin-Embedded TissueStefanie K Schwab, Peter S Harris, Cole Michel, et al.
Cells|February 23, 2020
Characterizing the Retinal Phenotype in the High-Fat Diet and Western Diet Mouse Models of PrediabetesBright Asare-Bediako, Sunil K Noothi, Sergio Li Calzi, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
The non-steroidal MR antagonist Finerenone reverses Western diet-induced kidney disease by regulating mitochondrial and lipid metabolism and inflammationKomuraiah Myakala, Xiaoxin X Wang, Nataliia Shults, et al.
Pageof 20

Showing results (151-160 of 198) with videos related to

Sort By:
Pageof 20
American Journal of Physiology. Renal Physiology|October 12, 2023
Farnesoid X receptor prevents neutrophil extracellular traps via reduced sphingosine-1-phosphate in chronic kidney diseaseBryce A Jones, Komuraiah Myakala, Mahilan Guha, et al.
Ebiomedicine|August 5, 2017
The Mechanism of Diabetic Retinopathy Pathogenesis Unifying Key Lipid Regulators, Sirtuin 1 and Liver X ReceptorSandra S Hammer, Eleni Beli, Nermin Kady, et al.
Cell Death and Differentiation|May 15, 2025
Cockayne syndrome mice reflect human kidney disease and are defective in de novo NAD biosynthesisKomal Pekhale, Vinod Tiwari, Mansoor Hussain, et al.
Journal of the American Heart Association|June 26, 2014
Endoplasmic reticulum stress effector CCAAT/enhancer-binding protein homologous protein (CHOP) regulates chronic kidney disease-induced vascular calcificationShinobu Miyazaki-Anzai, Masashi Masuda, Kimberly M Demos-Davies, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 25, 2012
Synthetic farnesoid X receptor agonists induce high-density lipoprotein-mediated transhepatic cholesterol efflux in mice and monkeys and prevent atherosclerosis in cholesteryl ester transfer protein transgenic low-density lipoprotein receptor (-/-) miceEva Hambruch, Shinobu Miyazaki-Anzai, Ulrike Hahn, et al.
The American Journal of Pathology|April 19, 2020
An in Situ Atlas of Mitochondrial DNA in Mammalian Tissues Reveals High Content in Stem and Proliferative CompartmentsJiayu Chen, Qizhi Zheng, Lauren B Peiffer, et al.
Biomedical Optics Express|May 16, 2019
Fully automated analysis of OCT imaging of human kidneys for prediction of post-transplant functionBrandon Konkel, Christopher Lavin, Tong Tong Wu, et al.
Proteomics. Clinical Applications|June 26, 2024
Quantifying Protein Acetylation in Diabetic Nephropathy from Formalin-Fixed Paraffin-Embedded TissueStefanie K Schwab, Peter S Harris, Cole Michel, et al.
Cells|February 23, 2020
Characterizing the Retinal Phenotype in the High-Fat Diet and Western Diet Mouse Models of PrediabetesBright Asare-Bediako, Sunil K Noothi, Sergio Li Calzi, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
The non-steroidal MR antagonist Finerenone reverses Western diet-induced kidney disease by regulating mitochondrial and lipid metabolism and inflammationKomuraiah Myakala, Xiaoxin X Wang, Nataliia Shults, et al.
Pageof 20